Patent · US Active

Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

US10047097B2 · kind B2 · utility

9Cited by
48References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 3, 2018
Grant dateAug 14, 2018
Priority date
Expiry dateJan 3, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.